J Neurogastroenterol Motil 2021; 27(3): 443-443  https://doi.org/10.5056/jnm18029A
Addendum
Published online: July 30, 2021
© The Korean Society of Neurogastroenterology and Motility. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases

Tadayuki Oshima and Hiroto Miwa

(J Neurogastroenterol Motil 2018;24(3):334-344; https://doi.org/10.5056/jnm18029)

We add the following information to the Conflicts of interest by the request of the author.

Conflicts of interest: Tadayuki Oshima has received lecture fees from Takeda Pharmaceutical Co, Ltd and Otsuka Pharmaceutical Co, Ltd. Hiroto Miwa has received research grants and lecture fees from Takeda Pharmaceutical Co, Ltd and Otsuka Pharmaceutical Co, Ltd.



This Article

e-submission

Archives

Aims and Scope